In the current study, we found that SsnB at 10 μM concentration suppresses the N-myc expression in IMR-32, NGP and SK-N-BE(2) cells (Figure 4) which might be correlated with the SsnB-mediated anticancer activity on human neuroblastoma cells. Here, MYCN is linked to neuroblastoma.